Yes, read the FDA's press release here.
Labcorp OnDemand®offers the Pixel by Labcorp COVID-19 tests and collection kits with an FDA Emergency Use Authorization (EUA). This means that while the laboratory performing these tests have validation data to support offering the tests and the collection kits, neither have been approved or cleared by the FDA. The tests have only been authorized by FDA for detection of nucleic acid from SARS-CoV-2 (i.e., the COVID-19 virus) for the COVID-19 only test, and for detection of nucleic acid from SARS-CoV-2, influenza A and/or influenza B, and RSV for the COVID-19 + Flu + RSV test, and not for any other virus or pathogen. The tests are only authorized during the duration of the COVID-19 emergency declaration by federal regulators. Labcorp may modify or cease to offer the tests and the test kits upon direction of state or federal regulators in its sole discretion. Please see the Patient Fact Sheet and the Health Care Provider Fact Sheet for additional information.